ConductScience.org, home

Paper8565748

High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.

Bonkovsky HL and 4 others. Dig Dis Sci, 1996. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial. Papers, record 8565748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8565748

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.
PubMed
Journal
Dig Dis Sci
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonkovsky HLH L
2Clifford BDB D
3Smith LJL J
4Allan CC
5Banner BB

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis CMajor topic
Interferon-alphaMajor topic
Alanine Transaminase
Chronic Disease
Female
Humans
Interferon alpha-2
Male
Recombinant Proteins
Recurrence

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DK 38825NIDDK NIH HHSUnited StatesR01DK038825PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11331310Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.J Med Virol1992https://conductscience.org/library/papers/1331310PubMed
21317338Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.Hepatology1992https://conductscience.org/library/papers/1317338PubMed
37542385A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.Mod Pathol1995https://conductscience.org/library/papers/7542385PubMed
414136243THE GALACTOSE ELIMINATION CAPACITY IN CONTROL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS OF THE LIVER.Acta Med Scand1964https://conductscience.org/library/papers/14136243PubMed
58014455Response to interferon alpha therapy is influenced by the iron content of the liver.J Hepatol1994https://conductscience.org/library/papers/8014455PubMed
67739691Interferon and hepatitis C.N Engl J Med1995https://conductscience.org/library/papers/7739691PubMed
77597443Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.Semin Liver Dis1995https://conductscience.org/library/papers/7597443PubMed
87598467Hepatitis C: an overview.Annu Rev Med1995https://conductscience.org/library/papers/7598467PubMed
97507462High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.Hepatology1994https://conductscience.org/library/papers/7507462PubMed
109011466Dose increase augments response rate to interferon-alpha in chronic hepatitis C.Dig Dis Sci1996https://conductscience.org/library/papers/9011466PubMed
117540996Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.Gastroenterology1995https://conductscience.org/library/papers/7540996PubMed
128521608Iron and chronic viral hepatitis: emerging evidence for an important interaction.Dig Dis1995https://conductscience.org/library/papers/8521608PubMed
137308988Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.Hepatology1981https://conductscience.org/library/papers/7308988PubMed
147982639Genotypic analysis of hepatitis C virus in American patients.Hepatology1994https://conductscience.org/library/papers/7982639PubMed
157977232A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C.Am J Gastroenterol1994https://conductscience.org/library/papers/7977232PubMed
167739681A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.N Engl J Med1995https://conductscience.org/library/papers/7739681PubMed
172509916Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.N Engl J Med1989https://conductscience.org/library/papers/2509916PubMed
187666045Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains.J Med Virol1995https://conductscience.org/library/papers/7666045PubMed
197739682Clinical outcomes after transfusion-associated hepatitis C.N Engl J Med1995https://conductscience.org/library/papers/7739682PubMed
207698578Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.Gastroenterology1995https://conductscience.org/library/papers/7698578PubMed

See all 26 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
23440791Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23440791PubMed
12076394Interferon for interferon naive patients with chronic hepatitis C.Cochrane Database Syst Rev2002https://conductscience.org/library/papers/12076394PubMed
9753286AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.Dig Dis Sci1998https://conductscience.org/library/papers/9753286PubMed
9246043Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.Dig Dis Sci1997https://conductscience.org/library/papers/9246043PubMed
9173207[Therapy of hepatitis C].Med Klin (Munich)1997https://conductscience.org/library/papers/9173207PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8565748

GET https://conductscience.org/api/papers/v1/8565748/references?page=2